Stevanato Group S.p.A. (STVN) Stock Forecast, Price Target & Predictions
STVN Stock Forecast
Stevanato Group S.p.A. stock forecast is as follows: an average price target of $25.50 (represents a 29.77% upside from STVN’s last price of $19.65) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
STVN Price Target
The average price target for Stevanato Group S.p.A. (STVN) is $25.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $33.00 to $19.00. This represents a potential 29.77% upside from STVN's last price of $19.65.
STVN Analyst Ratings
According to 3 Wall Street analysts, Stevanato Group S.p.A.'s rating consensus is 'Buy'. The analyst rating breakdown for STVN stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Stevanato Group S.p.A. Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 07, 2024 | Patrick Donnelly | Citigroup | - | - | 40.92% | 42.49% |
| Jul 15, 2024 | Drew Ranieri | Morgan Stanley | - | - | 1.34% | 11.96% |
| Sep 26, 2023 | Jacob Johnson | Stephens | - | - | 21.91% | 67.94% |
| Jan 06, 2023 | Morgan Stanley | - | - | 10.86% | 11.96% | |
| Apr 25, 2022 | Wells Fargo | - | - | 14.53% | -3.31% |
The latest Stevanato Group S.p.A. stock forecast, released on Aug 07, 2024 by Patrick Donnelly from Citigroup, set a price target of $28.00, which represents a 40.92% increase from the stock price at the time of the forecast ($19.87), and a 42.49% increase from STVN last price ($19.65).
Stevanato Group S.p.A. Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $25.00 |
| Last Closing Price | $19.65 | $19.65 | $19.65 |
| Upside/Downside | -100.00% | -100.00% | 27.23% |
In the current month, the average price target of Stevanato Group S.p.A. stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Stevanato Group S.p.A.'s last price of $19.65. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 07, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 15, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Sep 26, 2023 | Stephens | Overweight | Initialise | |
| Jul 31, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
| Jan 06, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Stevanato Group S.p.A.'s last stock rating was published by Citigroup on Aug 07, 2024. The company gave STVN a "Buy" rating, the same as its previous rate.
Stevanato Group S.p.A. Financial Forecast
Stevanato Group S.p.A. Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $237.99M | $292.10M | $245.26M | $234.25M | $212.07M | $232.57M | $214.53M | $203.96M |
| Avg Forecast | $411.86M | $364.68M | $342.65M | $307.93M | $365.17M | $315.09M | $291.96M | $264.03M | $339.18M | $305.48M | $273.05M | $255.91M | $360.76M | $296.37M | $273.31M | $253.70M | $290.99M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| High Forecast | $418.76M | $370.78M | $348.39M | $313.09M | $371.29M | $320.36M | $296.85M | $268.00M | $345.10M | $310.60M | $277.63M | $260.20M | $365.36M | $301.33M | $277.88M | $257.95M | $295.87M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| Low Forecast | $405.84M | $359.35M | $337.65M | $303.43M | $359.83M | $310.48M | $287.69M | $260.05M | $334.24M | $301.02M | $269.06M | $252.18M | $352.88M | $292.04M | $269.31M | $249.99M | $286.74M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 2 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 1.00% | 1.02% | 0.98% | 0.90% | 0.93% | 0.90% | 0.85% |
Stevanato Group S.p.A.'s average Quarter revenue forecast for Jun 23 based on 4 analysts is $273.31M, with a low forecast of $269.31M, and a high forecast of $277.88M. STVN's average Quarter revenue forecast represents a 14.84% increase compared to the company's last Quarter revenue of $237.99M (Mar 23).
Stevanato Group S.p.A. EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 2 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $59.21M | $70.90M | $64.42M | $59.88M | $53.31M | $59.86M | $41.76M | $61.55M |
| Avg Forecast | $100.10M | $88.63M | $83.28M | $74.84M | $88.75M | $76.58M | $70.96M | $64.17M | $82.44M | $74.25M | $66.37M | $62.20M | $87.68M | $72.03M | $66.43M | $61.66M | $70.73M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $39.79M |
| High Forecast | $101.78M | $90.12M | $84.68M | $76.10M | $90.24M | $77.86M | $72.15M | $65.14M | $83.88M | $75.49M | $67.48M | $63.24M | $88.80M | $73.24M | $67.54M | $62.69M | $71.91M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $47.75M |
| Low Forecast | $98.64M | $87.34M | $82.06M | $73.75M | $87.46M | $75.46M | $69.92M | $63.21M | $81.24M | $73.16M | $65.40M | $61.29M | $85.77M | $70.98M | $65.46M | $60.76M | $69.69M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $31.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 1.00% | 1.19% | 1.11% | 1.01% | 1.06% | 0.78% | 1.55% |
4 analysts predict STVN's average Quarter EBITDA for Jun 23 to be $66.43M, with a high of $67.54M and a low of $65.46M. This is 12.19% upper than Stevanato Group S.p.A.'s previous annual EBITDA (Mar 23) of $59.21M.
Stevanato Group S.p.A. Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 2 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $28.27M | $48.30M | $36.22M | $30.53M | $27.72M | $44.60M | $18.66M | $34.44M |
| Avg Forecast | $68.37M | $57.30M | $47.67M | $40.32M | $53.32M | $42.54M | $33.35M | $28.06M | $52.97M | $38.51M | $28.67M | $32.51M | $57.64M | $43.85M | $38.77M | $35.54M | $46.38M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $21.92M |
| High Forecast | $69.86M | $58.54M | $48.70M | $41.19M | $54.48M | $43.47M | $34.07M | $28.67M | $55.62M | $39.35M | $29.36M | $33.76M | $58.89M | $44.79M | $39.61M | $36.32M | $47.39M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $26.30M |
| Low Forecast | $67.07M | $56.21M | $46.76M | $39.55M | $52.31M | $41.73M | $32.71M | $25.72M | $50.32M | $37.78M | $27.99M | $31.27M | $54.90M | $42.91M | $38.03M | $34.87M | $45.50M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $17.53M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.80% | 1.04% | 1.02% | 0.92% | 0.91% | 1.41% | 0.62% | 1.57% |
Stevanato Group S.p.A.'s average Quarter net income forecast for Jun 23 is $38.77M, with a range of $38.03M to $39.61M. STVN's average Quarter net income forecast represents a 37.15% increase compared to the company's last Quarter net income of $28.27M (Mar 23).
Stevanato Group S.p.A. SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 2 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $28.27M | $33.20M | $25.82M | $29.35M | $23.42M | $22.25M | $29.37M | $11.45M |
| Avg Forecast | $47.69M | $42.23M | $39.68M | $35.66M | $42.29M | $36.49M | $33.81M | $30.58M | $39.28M | $35.38M | $31.62M | $29.64M | $41.78M | $34.32M | $31.65M | $29.38M | $33.70M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $7.29M |
| High Forecast | $48.49M | $42.94M | $40.34M | $36.26M | $43.00M | $37.10M | $34.38M | $31.04M | $39.96M | $35.97M | $32.15M | $30.13M | $42.31M | $34.90M | $32.18M | $29.87M | $34.26M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $8.75M |
| Low Forecast | $47.00M | $41.61M | $39.10M | $35.14M | $41.67M | $35.95M | $33.32M | $30.11M | $38.71M | $34.86M | $31.16M | $29.20M | $40.86M | $33.82M | $31.19M | $28.95M | $33.21M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $5.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.99% | 0.94% | 1.07% | 0.87% | 0.78% | 1.08% | 1.57% |
Stevanato Group S.p.A.'s average Quarter SG&A projection for Jun 23 is $31.65M, based on 4 Wall Street analysts, with a range of $31.19M to $32.18M. The forecast indicates a 11.94% rise compared to STVN last annual SG&A of $28.27M (Mar 23).
Stevanato Group S.p.A. EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 2 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.11 | $0.18 | $0.14 | $0.12 | $0.10 | $0.17 | $0.07 | $0.11 |
| Avg Forecast | $0.25 | $0.21 | $0.17 | $0.15 | $0.20 | $0.16 | $0.12 | $0.10 | $0.19 | $0.14 | $0.11 | $0.12 | $0.21 | $0.16 | $0.14 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| High Forecast | $0.26 | $0.21 | $0.18 | $0.15 | $0.20 | $0.16 | $0.12 | $0.11 | $0.20 | $0.14 | $0.11 | $0.12 | $0.22 | $0.16 | $0.15 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| Low Forecast | $0.25 | $0.21 | $0.17 | $0.14 | $0.19 | $0.15 | $0.12 | $0.09 | $0.18 | $0.14 | $0.10 | $0.11 | $0.20 | $0.16 | $0.14 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.84% | 1.06% | 1.08% | 0.98% | 0.90% | 1.47% | 0.64% | 0.74% |
According to 4 Wall Street analysts, Stevanato Group S.p.A.'s projected average Quarter EPS for Jun 23 is $0.14, with a low estimate of $0.14 and a high estimate of $0.15. This represents a 29.15% increase compared to STVN previous annual EPS of $0.11 (Mar 23).
Stevanato Group S.p.A. Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | - | - | 195.63% | Buy |
| AKYA | Akoya Biosciences | - | - | 151.18% | Buy |
| ANGO | AngioDynamics | - | - | 119.62% | Buy |
| XRAY | DENTSPLY SIRONA | - | - | 113.11% | Hold |
| TFX | Teleflex | - | - | 58.76% | Buy |
| ATRC | AtriCure | - | - | 38.70% | Buy |
| STVN | Stevanato Group S.p.A. | - | - | 29.77% | Buy |
| HAE | Haemonetics | - | - | 26.53% | Buy |
| ALC | Alcon | - | - | 9.19% | Buy |
| NVST | Envista | - | - | 7.59% | Hold |
| ICUI | ICU Medical | - | - | 2.10% | Buy |
| MMSI | Merit Medical Systems | - | - | -4.32% | Buy |
| WST | West Pharmaceutical Services | - | - | -5.98% | Buy |
| RMD | ResMed | - | - | -10.11% | Hold |
| ATR | AptarGroup | - | - | -19.54% | Buy |